Skip to main content
G

GUANGDONG BIOLIGHT MEDITECH CO.,LTD. — Investor Relations & Filings

Ticker · 300246 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,040 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300246

About GUANGDONG BIOLIGHT MEDITECH CO.,LTD.

https://www.blt.com.cn

Guangdong Biolight Meditech Co., Ltd. specializes in the research, development, and manufacturing of medical electronic equipment and healthcare solutions. The company’s core product portfolio includes advanced patient monitoring systems, such as multi-parameter monitors, electrocardiographs, and pulse oximeters. It maintains a significant presence in the renal care sector, providing integrated hemodialysis solutions that encompass dialysis machines, dialyzers, and specialized consumables. Additionally, the company develops home healthcare products and digital health management platforms designed to improve clinical workflows and patient outcomes. By integrating hardware with cloud-based data services, the company provides comprehensive diagnostic and therapeutic tools for global healthcare providers, focusing on technical innovation and high-precision medical instrumentation.

Recent filings

Filing Released Lang Actions
关于2026年度日常关联交易预计的公告
Regulatory Filings Classification · 1% confidence The document is a public announcement (“公告”) by Guangdong BOLIOTE Medical Technology Co., Ltd. regarding the estimated 2026 annual related-party transactions (“日常关联交易预计的公告”). It provides details of transactions with affiliates, governance approvals, pricing principles, and board/independent director opinions. It is not a financial report itself (e.g., annual or interim report), not an earnings release, not a call transcript, not a dividend notice, nor any of the other specific categories. It falls under miscellaneous regulatory disclosures. Therefore, it should be classified as a general Regulatory Filing (RNS).
2026-04-24 Chinese
独立董事2025年度述职报告（薛俊东）
Governance Information Classification · 1% confidence The document is an annual performance report by an independent director detailing his duties, board meeting attendance, committee work, compliance with governance regulations, and suggestions for corporate governance improvements. This content aligns with Governance Information (CGR), which covers reports on internal rules, board structure, and governance practices. It is neither a change announcement (MANG) nor a financial results release (ER/IR), and is too substantive to be a mere publication announcement (RPA).
2026-04-24 Chinese
独立董事2025年度述职报告（冉茂良）
Governance Information Classification · 1% confidence The document is an annual performance and duty report by an independent director to the board and shareholders, detailing governance activities, meeting attendance, committee work, and oversight in accordance with corporate law and governance rules. It is a governance-related report rather than a financial statement, earnings release, or simple announcement. This aligns with “Governance Information” (CGR).
2026-04-24 Chinese
内幕信息知情人管理制度（2026年4月修订）
Governance Information Classification · 1% confidence The document is the full text of the company’s internal Insider Information Management System (“内幕信息知情人管理制度”), detailing definitions, procedures, responsibilities, and governance rules for insider information insiders. It is not an announcement of results or a summary but a substantive corporate governance policy document. This aligns with the Governance Information category, which covers internal rules and governance practices.
2026-04-24 Chinese
战略委员会工作细则（2026年4月修订）
Governance Information Classification · 1% confidence The document is the Board of Directors’ Strategic Committee Working Rules (a set of internal governance bylaws and procedures) issued by Guangdong Bolight Medical Technology Co. It details the committee’s composition, duties, meeting rules, voting procedures, conflict of interest and other governance structures. It is not an announcement of a meeting result, financial report, or regulatory notice, but rather internal governance documentation. Therefore, it falls under Governance Information (CGR).
2026-04-24 Chinese
第九届董事会第八次会议决议公告
Regulatory Filings Classification · 0% confidence The document is a formal announcement of the resolutions passed at the ninth board of directors’ eighth meeting of Guangdong Baolaite Medical Technology Co., Ltd. It lists agenda items, voting outcomes, and refers to publication of detailed reports elsewhere. It is not an earnings release, full financial report, proxy statement, remuneration report, or management change notice. It is a mandated regulatory disclosure of board meeting resolutions, which does not fit any more specific category, so it falls under the general “Regulatory Filings” fallback.
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.